SCHEMBL2172030

SCHEMBL2172030

COc1ccc(OC)c(CNC(=O)c2csc(CNC(=O)COc3ccc(OC(F)(F)F)cc3)n2)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.51
CYP1A2 P05177 3/20 0.51
CYP3A4 P08684 3/20 0.51
CYP2C9 P11712 3/20 0.51
CYP2C19 P33261 3/20 0.51
MAPK8 P45983 3/20 0.47
MAPK9 P45984 2/20 0.47
MAPK10 P53779 2/20 0.47
POLB P06746 1/20 0.46
HTT P42858 2/20 0.44
NPSR1 Q6W5P4 1/20 0.44
PPARG P37231 1/20 0.44
PPARD Q03181 1/20 0.44
PPARA Q07869 1/20 0.44
NPC1 O15118 2/20 0.43
RAB9A P51151 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
CYP2D6 P10635 1/20 0.42
ABCB1 P08183 1/20 0.42
MAPK1 P28482 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4390910 0.91 MAPT (0.61) MAPTCYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL5670152 0.88 CYP1A2 (0.50) MAPTCYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL2176692 0.87 MAPT (0.52) MAPTCYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL4390529 0.87 CYP1A2 (0.62) MAPTCYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL5668972 0.86 NPC1 (0.52) MAPTCYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL4397607 0.83 CYP1A2 (0.46) MAPTCYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL4392420 0.83 CYP1A2 (0.52) MAPTCYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL4391359 0.83 MEN1 (0.42) MAPTCYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL2172250 0.82 MEN1 (0.45) MAPTCYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL4383676 0.82 MAPT (0.44) MAPTCYP1A2CYP3A4CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7973061-B2 Anaplastic lymphoma kinase modulators and methods of use EXELIXIS, INC. (US) 2011-07-05 US claimed
EP-1730128-A1 ANAPLASTIC LYMPHOMA KINASE MODULATORS AND METHODS OF USE Exelixis, Inc. (US) 2006-12-13 EP claimed
WO-2005097765-A1 ANAPLASTIC LYMPHOMA KINASE MODULATORS AND METHODS OF USE EXELIXIS, INC. (US) 2005-10-20 WO claimed